Grifols to Testify in Canada Amid Plasma Safety Scrutiny

Spanish drugmaker Grifols SA will address a parliamentary hearing in Canada, amid growing public scrutiny following the recent death of two patients who had made blood plasma donations.

Mary Hughes, Grifols’ vice-president of sales in Canada, is due to testify before a health committee on March 26 in Ottawa, according to the House of Commons website. Other pharmaceutical industry representatives have also been summoned.